Tumor Protein P53 Inducible Nuclear Protein 2 (TP53INP2) (C-Term) Peptide
-
- Target See all TP53INP2 products
- TP53INP2 (Tumor Protein P53 Inducible Nuclear Protein 2 (TP53INP2))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- RLQRARQRAE RHALSAKAVQ RQNRARESRP RRSKNQSSFI YQPCQRQFNY
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TP53INP2 Antibody(ARP58965_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TP53INP2 (Tumor Protein P53 Inducible Nuclear Protein 2 (TP53INP2))
- Background
-
The function of TP53INP2 remains unknown.
Alias Symbols: C20orf110, DKFZp434B2411, DKFZp434O0827, DOR, FLJ21759, FLJ23500, PINH, dJ1181N3.1
Protein Size: 220 - Molecular Weight
- 24 kDa
- Gene ID
- 58476
- NCBI Accession
- NM_021202, NP_067025
- UniProt
- Q8IXH6
-